Top Markets
#1 MowCat MowCat +369.14%
#2 龙虾 (Lobster) 龙虾 (Lobster) +66.90%
#3 SODAX SODAX +51.90%
#4 Cortex Cortex +33.34%
#5 DexNet DexNet +23.19%
#6 OpenEden OpenEden +21.97%
#7 BNB Attestation Service BNB Attestation Service +20.72%
#8 Magma Finance Magma Finance +16.49%
#9 wojak wojak +16.15%
#10 Akedo Akedo +16.13%
Coin of the day
MowCat MowCat
設定
言語
日本
通貨
USD
テーマ
Avalyn Pharma Inc. Common Stock Avalyn Pharma Inc. Common Stock

Avalyn Pharma Inc. Common Stock

AVLN
株式のランク #7326
Avalyn Pharma Inc. operates as a biopharmaceutical firm currently in its... Avalyn Pharma Inc. operates as a biopharmaceutical firm currently in its clinical development phase. The company's primary focus is on creating inhaled pharmaceutical products to manage rare lung conditions, including pulmonary fibrosis and various other interstitial lung diseases (ILDs). Richard Glenn Vincent, Mark W. Surber, and Michael J. Kamdar co-founded the enterprise on May 27, 2011, and its corporate headquarters are situated in Boston, Massachusetts.
株価
$36.75
最終同期: 2026-08-27
時価総額
$1.63B
変化（1日）
-0.78%
変化（1年）
-
国
US
取引 Avalyn Pharma Inc. Common Stock (AVLN)

カテゴリー

Healthcare
Avalyn Pharma Inc. Common Stock（AVLN）の配当利回りの履歴
Avalyn Pharma Inc. Common Stock（銘柄コード: AVLN）の配当利回り（TTM）は2026時点で0です。
過去5年間の平均配当利回り: 0.00%
Avalyn Pharma Inc. Common Stock（AVLN）の2026から2026までの配当利回りの履歴
各年末時点の配当利回り（TTM）
年 配当利回り 変化
提供された日付のデータは十分ではありません。
類似企業または競合他社の配当利回り（TTM）
企業 配当利回り 国
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
0.00%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
0.00%
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
3.12%
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
0.00%
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
0.00%
CH